Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADONIS-PCI
2024-515056-20-00Phase 3Completed
- Sponsor
- Medical University of Gdańsk
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ticagrelor and dabigatran in acute coronary syndrome (ACS) and Atrial fibrillation (AFib), sponsored by Medical University of Gdańsk. Started Nov 2024; status: completed.
02
Drugs
ticagrelordabigatran
03
Conditions
acute coronary syndrome (ACS)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2024-515056-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515056-20-00.